Judy Schnyder

Ms. Schnyder has served as the Sr. Vice President, Clinical Operations and Data Management since January 2022 and previously as Vice President, Clinical Operations since October 2020.

Ms. Schnyder has over 20 years of Clinical Operations experience in oncology, dermatology, and immunology. Prior to joining Galera, Ms. Schnyder served as Executive Director of Clinical Operations at Aclaris Therapeutics where she built out a Clinical Operations and Data Management team responsible for the development of novel dermatology and immune-inflammatory assets. Ms. Schnyder has held Clinical Operations and Development positions at Lycera, Tetralogic, Gemin X Pharmaceuticals (acquired by Cephalon), GSK, PharmaNet, and Cephalon. She began her career in Clinical Operations at U.S. Bioscience (MedImmune).

Ms. Schnyder holds a Bachelors degree in Biology from Lafayette College and a Masters of Business Administration with a concentration in Health Care Administration from Widener University.